[go: up one dir, main page]

GB0712683D0 - Improvements relating to oxygen-carrying proteins(1) - Google Patents

Improvements relating to oxygen-carrying proteins(1)

Info

Publication number
GB0712683D0
GB0712683D0 GBGB0712683.2A GB0712683A GB0712683D0 GB 0712683 D0 GB0712683 D0 GB 0712683D0 GB 0712683 A GB0712683 A GB 0712683A GB 0712683 D0 GB0712683 D0 GB 0712683D0
Authority
GB
United Kingdom
Prior art keywords
oxygen
improvements relating
carrying proteins
proteins
carrying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0712683.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Essex Enterprises Ltd
Original Assignee
University of Essex Enterprises Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Essex Enterprises Ltd filed Critical University of Essex Enterprises Ltd
Priority to GBGB0712683.2A priority Critical patent/GB0712683D0/en
Publication of GB0712683D0 publication Critical patent/GB0712683D0/en
Priority to PCT/GB2008/002203 priority patent/WO2009004310A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6445—Haemoglobin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GBGB0712683.2A 2007-06-29 2007-06-29 Improvements relating to oxygen-carrying proteins(1) Ceased GB0712683D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0712683.2A GB0712683D0 (en) 2007-06-29 2007-06-29 Improvements relating to oxygen-carrying proteins(1)
PCT/GB2008/002203 WO2009004310A1 (en) 2007-06-29 2008-06-26 Modified globin proteins with attenuated electron transport pathway

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0712683.2A GB0712683D0 (en) 2007-06-29 2007-06-29 Improvements relating to oxygen-carrying proteins(1)

Publications (1)

Publication Number Publication Date
GB0712683D0 true GB0712683D0 (en) 2007-08-08

Family

ID=38420972

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0712683.2A Ceased GB0712683D0 (en) 2007-06-29 2007-06-29 Improvements relating to oxygen-carrying proteins(1)

Country Status (2)

Country Link
GB (1) GB0712683D0 (en)
WO (1) WO2009004310A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0712685D0 (en) 2007-06-29 2007-08-08 Wivenhoe Technology Ltd Improvements relating to oxygen-carrying proteins (2)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8711614D0 (en) * 1987-05-16 1987-06-24 Medical Res Council Proteins
US5922854A (en) * 1991-06-14 1999-07-13 Kumar; Ramesh Purifying Human Hemogloblin from transgenic pig red cells and plasmids containing pig globin nucleic acids
US6114505A (en) * 1995-10-23 2000-09-05 William Marsh Rice University Hemoglobin mutants that reduce heme loss

Also Published As

Publication number Publication date
WO2009004310A1 (en) 2009-01-08

Similar Documents

Publication Publication Date Title
GB2422174B (en) Improvements relating to clamps
ZA200900027B (en) Improvements relating to anti-parasitic compositions
GB2443778B (en) Improvements relating to lighting
GB0620861D0 (en) Improvements in or relating to stairlifts
GB0611116D0 (en) Proteins
EP1986507A4 (en) Moisturizing composition for protein materials
GB0601976D0 (en) Proteins
GB0620735D0 (en) Proteins
GB0712685D0 (en) Improvements relating to oxygen-carrying proteins (2)
GB2435463B (en) Improvements in or relating to stairlifts
GB0712683D0 (en) Improvements relating to oxygen-carrying proteins(1)
GB0410324D0 (en) Improvements relating to engines
GB0602618D0 (en) Improvements in or relating to stairlifts
GB0500956D0 (en) Improvements relating to emulsions
GB0611600D0 (en) Improvements to membranes
GB0507990D0 (en) Improvements relating to lantibiotics
GB0614682D0 (en) Proteins
GB0612623D0 (en) Proteins
GB0504183D0 (en) Improvements relating to mops
GB2423802B (en) Improvements relating to vacuum-brake-boosters
GB0513572D0 (en) Improvements relating to binders
SI1904636T1 (en) Improvements in or relating to protein production
GB2427850B (en) Improvements relating to binders
GB0712104D0 (en) 4 transmembrane protein
GB0602928D0 (en) Improvements relating to clothing

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)